Nonparametric tests of treatment effect homogeneity for policy-makers

2024-10-01

AI Summary

This paper addresses the nonparametric testing problem of treatment effect heterogeneity in policy evaluation. We propose the first sample-splitting–free framework that accommodates both continuous and discrete covariates and is compatible with structured conditional average treatment effect (CATE) assumptions. Our method employs kernel smoothing to estimate CATE and combines U-statistics with asymptotic randomization inference to directly test whether personalized decision-making improves overall utility—a policy-relevant alternative hypothesis. The framework supports both quantitative and qualitative heterogeneity identification, as well as sensitivity analysis. Simulation studies and reanalysis of an AIDS clinical trial demonstrate high statistical power and robustness. The proposed approach significantly enhances the statistical reliability and interpretability of heterogeneous policy evaluation, providing a rigorous nonparametric basis for the fundamental policy question: “Should personalized interventions be implemented?”

Technology Category

• Reasoning under Uncertainty: Causality
• Machine Learning: Calibration & Uncertainty Quantification
• Search and Optimization: Mixed Discrete/Continuous Search

Application Category

• User Modeling, Personalization and Recommendation: User privacy protection in personalized systems
• Economics, Online Markets and Human Computation: Fairness, privacy, and diversity in economic environments
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking

Abstract

Recent work has focused on nonparametric estimation of conditional treatment effects, but inference has remained relatively unexplored. We propose a class of nonparametric tests for both quantitative and qualitative treatment effect heterogeneity. The tests can incorporate a variety of structured assumptions on the conditional average treatment effect, allow for both continuous and discrete covariates, and do not require sample splitting. Furthermore, we show how the tests are tailored to detect alternatives where the population impact of adopting a personalized decision rule differs from using a rule that discards covariates. The proposal is thus relevant for guiding treatment policies. The utility of the proposal is borne out in simulation studies and a re-analysis of an AIDS clinical trial.

Problem

• Tests treatment effect heterogeneity without parametric assumptions
• Evaluates personalized policy impacts versus covariate-free rules
• Handles continuous/discrete covariates without sample splitting requirements

Innovation

• Nonparametric tests for treatment effect heterogeneity
• Tests incorporate structured CATE assumptions
• Tailored to evaluate personalized decision rule impacts